New: the Income Securities Screening Form now screens by price, yield, S&P rating, call status and trading volume, and you can save your searches to run again. Try the updated form.
IRulya Therapeutics Inc. (IRLA)
IRLA · NCM · · CUSIP 22053A305
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for IRLA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
22053A305
IPO
5/9/2019 · 4.41 Million Shares @ $17.00/share
Prospectus
IPO prospectus »
Previous Symbol
CRTX (changed 7/29/2022)
Previous Name
Cortexyme, Inc.
Business: Cortexyme, Inc. is a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform the lives of patients suffering from debilitating and rare diseases.
Notes: AUTO-CRE

Company Contact

CEO
Dirk Thye
CFO
Brendan Hannah
Headquarters
611 Gateway Boulevard, Suite 273, South San Francisco, CA 94080
Phone
415-910-5717
Investor Relations
Stacy Roughan · 415-910-5717 · ir@quincetx.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »